Stock Events

Stock Events

Edwards Lifesciences 

€70.82
290
-€0.28-0.39% Tuesday 19:55

Statistics

Day High
71.64
Day Low
70.52
52W High
74.88
52W Low
62.41
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2025
Q1 2026
Next
0.49
0.55
0.61
0.67
Expected EPS
0.63418909799
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EWL.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap112.88B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap8.88B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap830.03M
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

About

There is no Profile data available for EWL.SG.
Show more...
CEO
Country
United States
ISIN
US28176E1082

Listings

MU
DE
EWL.MU
STU
DE
EWL.STU
MX
MX
EW.MX
LSE
GB
0REN.LSE

0 Comments

Share your thoughts

FAQ

What is Edwards Lifesciences stock price today?▼
The current price of EWL.STU is €70.82 EUR — it has decreased by -0.39% in the past 24 hours. Watch Edwards Lifesciences stock price performance more closely on the chart.
What is Edwards Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Edwards Lifesciences stocks are traded under the ticker EWL.STU.
Is Edwards Lifesciences stock price growing?▼
EWL.STU stock has risen by +1.75% compared to the previous week, the month change is a +1.26% rise, over the last year Edwards Lifesciences has showed a +7.22% increase.
When is the next Edwards Lifesciences earnings date?▼
Edwards Lifesciences is going to release the next earnings report on July 23, 2026.
What were Edwards Lifesciences earnings last quarter?▼
EWL.STU earnings for the last quarter are 0.67 EUR per share, whereas the estimation was 0.62 EUR resulting in a +6.98% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Edwards Lifesciences located?▼
Edwards Lifesciences operates in the Materials sector.
When did Edwards Lifesciences complete a stock split?▼
The last stock split for Edwards Lifesciences was on June 01, 2020 with a ratio of 2:1.